Ponesimod Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 20 mg
Reference Brands: Ponvory(US & EU)
Category:
Multiple sclerosis
Ponesimod is a selective sphingosine-1-phosphate receptor modulator that prevents lymphocyte migration, reducing neuroinflammation. It decreases relapse rates and slows disease progression in multiple sclerosis. Benefits include oral dosing, targeted immune regulation, reduced relapse frequency, and improved quality of life for patients with relapsing MS.
Ponesimod tablets is available in Tablet
and strengths such as 20 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ponesimod tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ponesimod tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Ponesimod, marketed as Gilyea, is approved in the US by the FDA and in the EU via EMA for relapsing multiple sclerosis (MS). Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, FDA review involves comprehensive analysis of clinical trial results and manufacturing standards, while the EMA ensures compliance with regional safety and quality regulations.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing